All In MedTech

FDA Clearance Tracker · P150004-S071

Family of DRG IPGs

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 26, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 26, 2024

Approved

Time to decision

89 days

Received Mar 29, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150004-S071
Device name
Family of DRG IPGs
Applicant location
Plano, TX
Received
Mar 29, 2024
Decided
Jun 26, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150004

Device type

Device class
Class III

Every decision under product code PMP

FDA's approval statement

As written in FDA's record.

Approval for: • Version 4.00 of the Patient Controller Application to be run on the Android OS that combines the two Patient Controller Applications approved in P010032/S187 (Patient Controller Application version 3.11) and P010032/S202 (Patient Controller Application version 2.00). • Predetermined Change Control Plan (PCCP) of the Patient Controller Application version 4.00 to be run on the Apple iOS.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.